본문 바로가기
본문

과제정보

과제명, 기관명, 담당부서, 전화번호, 연구기간, 연구분야, 과제개요의 정보를 제공합니다.
과제명 2005년도OECD보건통계생산및신부전환자실태조사
기관명 보건복지부 담당부서
전화번호 연구기간 2004-07-15 ~ 2005-06-30
연구분야
과제개요 2005년도OECD보건통계생산및신부전환자실태조사

계약정보

수행기관, 수행연구원, 계약일자, 계약방식, 계약금액의 정보를 제공합니다.
수행기관 한국보건사회연구원
수행연구원 장영식 계약일자  
계약방식 기타 계약금액 0원

연구결과정보

제목, 연구보고서, 공개제한근거, 비공개사유, 연구보고서, 목차, 주제어, 공헌자, 제작일, 발행년도의 정보를 제공합니다.
제목 2005年度 OECD 保健統計生産 및 腎不全患者實態調査
연구보고서 비공개 ( 이후 공개 예정) 공개제한근거
※ 이 정책연구는 공개예정일자에 연구수행 부서에서 공개가능 여부를 재검토하며, 비공개 기간이 연장될 수 있습니다.
비공개사유
목차
    要 約······················································································································· 13
    第1章 序 論············································································································· 26
    第1節 硏究의 背景·································································································· 26
    第2節 硏究의 目的·································································································· 28
    第3節 硏究의 內容 및 方法····················································································· 30
    第2章 OECD 保健統計의 範疇···················································································· 32
    第1節 OECD 保健統計 要求動向·············································································· 32
    第2節 OECD 保健統計 部門別 要求動向··································································· 32
    第3章 OECD 會員國의 保健統計 生産水準 比較·························································· 36
    第1節 保健統計 提出水準: 2004 ··············································································· 36
    第4章 2005年 OECD 保健統計 提出 現況···································································· 40
    第1節 健康狀態······································································································· 44
    1. 期待餘命········································································································· 44
    2. 母性 및 ?兒死亡···························································································· 46
    3. 認知하고 있는 健康狀態··················································································· 48
    4. ?兒健康········································································································· 50
    5. 先天性異常······································································································ 51
    6. 齒牙健康········································································································· 53
    7. 傳染病············································································································ 53
    8. 傷害··············································································································· 54
    9. 缺勤··············································································································· 55
    第2節 保健醫療資源································································································ 56
    1. 保健部門 從事者······························································································ 56
    2. 保健專門人 所得······························································································ 59
    3. 病床數············································································································ 60
    4. 病床當 人力比率······························································································ 62
    5. 尖端醫療裝備··································································································· 62
    第3節 保健醫療利用································································································ 64
    1. 豫防接種········································································································· 64
    2. 外來診療活動··································································································· 65
    3. 入院施設········································································································· 66
    4. 平均入院期間··································································································· 68
    5. 診斷範疇別 平均入院期間················································································· 69
    6. 診斷範疇別 退院率··························································································· 74
    7. 外科手術········································································································· 79
    8. ICD-CM別 外科的手術····················································································· 79
    9. 移植··············································································································· 82
    第4節 保健支出費用································································································ 84
    1. 保健部門總支出······························································································· 85
    2. 個人保健醫療費······························································································· 87
    3. 集團的 保健醫療費··························································································· 88
    4. 豫防 및 公衆保健···························································································· 89
    5. 事業運營 및 醫療保險支出··············································································· 90
    6. 醫療서비스 總支出··························································································· 91
    7. 入院治療費用··································································································· 92
    8. 晝間治療費用··································································································· 94
    9. 外來治療費用··································································································· 95
    10. 在家保健서비스 ······························································································· 97
    11. 補助서비스 ······································································································ 98
    12. 總醫療用品費································································································· 100
    13. 醫藥品··········································································································· 101
    14. 治療機器 및 醫療裝備···················································································· 102
    15. 供給者別 保健費用························································································· 103
    16. 財源別 保健醫療費························································································· 105
    17. 保健關聯 費用······························································································· 107
    18. 年齡層別 費用······························································································· 108
    19. 物價指數······································································································· 109
    第5節 社會保障····································································································· 111
    1. 適用範圍······································································································· 111
    第6節 醫藥品市場··································································································· 113
    1. 醫藥品消費···································································································· 113
    2. 醫藥品 販賣··································································································· 116
    第7節 保健의 非醫療 決定要因·············································································· 119
    1. 酒類消費······································································································· 119
    2. 담배 消費······································································································ 120
    3. 體重 및 體形································································································· 121
    第5章 腎不全患者 實態····························································································· 123
    第1節 腎不全患者實態 把握의 必要性····································································· 123
    第2節 腎不全患者 把握方法··················································································· 124
    第3節 腎不全患者 推定 관련 硏究·········································································· 124
    第4節 腎不全患者 調査結果··················································································· 126
    第6章 OECD 要求 未生産統計의 生産方案································································· 145
    第1節 未生産統計의 生産方案················································································ 145
    第2節 未生産統計의 長短期生産計劃······································································ 149
    1. 短期生産計劃································································································· 150
    2. 中長期生産計劃······························································································ 151
    第7章 要約 및 政策提言··························································································· 153
    參 考 文 獻············································································································· 157
    附 錄····················································································································· 161
초록
    1. 硏究의 背景
    ■ 우리나라는 경제발전도모와 국제적인 경제협력을 위하여 1996년 12월 경제선진국의
    모임인 OECD (Organization for Economic Cooperation and Development)에 가입하였음.
    ■ OECD 가입과 함께 우리나라는 일반적 의무에 해당하는 통계제출의무를 갖게 되었으
    며, 보건통계는 OECD에서 요구하고 있는 다양한 통계 중의 하나에 해당함.
    ■ OECD에서 요구하는 보건통계는 보건정책의 수립 및 평가에 각국이 필요로 하는 통계
    를 우선하여 요구하고 있음. 따라서 OECD에 제공을 위하여 생산 제공된 통계는 우리
    나라의 보건정책에 매우 중요한 통계로 활용될 수 있음.
    ■ OECD에서 요구하는 통계는 자료원과 방법을 함께 요구하면서 기본적인 생산기준을
    제시하고 있기 때문에 제출된 통계는 회원국간 비교 등에 매우 유용한 자료로 활용될
    수 있음.
    ■ 그러나 아직까지 우리나라의 보건통계 수준은 만족할 만한 수준은 아님. 통계생산은
    일시적인 노력으로 가능한 경우도 있지만 효용성을 높이기 위하여는 지속적인 노력을
    통한 시계열적인 자료생산이 이루어질 수 있도록 통계생산 기반구축에 대한 노력과
    관심을 기울여야 할 것임.
    2. 硏究의 目的
    ■ 본 연구의 목적은 1차적으로 OECD에서 요구하는 보건통계를 효율적으로 제공하여
    OECD 회원국으로서 의무를 이행하고, 2차적으로 우리나라의 보건통계생산 확충과 지
    속적인 통계생산 기반을 마련하는 데 있음.
    ■ 변화하는 OECD의 통계항목에 보다 적절히 대응할 수 있는 방안을 마련하는 것임.
    ■ 생산 제공된 통계는 OECD에서 취합 제공됨으로서 보다 유용하게 각 회원국뿐만 아니
    라 회원국이 아닌 국가에서도 정책자료 및 연구자료로 유용하게 활용할 수 있음.
    ■ 이와 같은 연구를 통하여 OECD, WHO 등 국제기구의 통계요구수요에 능동적으로 대
    응할 수 있을 뿐 만 아니라 정책 활용도를 높일 수 있을 것임.
    3. 硏究의 內容 및 方法
    ■ 2005년 요구 통계항목은 2004년도와 어떤 변화가 있는지, 각 항목의 통계작성 기준은
    어떠한지 등을 살펴보고 가능한 OECD 요구 기준에 따른 통계 생산방안을 모색함.
    ■ 2004년도에 우리나라에서 OECD에 제출하여 ‘OECD Health Data 2004’에 수록된 보건
    통계자료 중 기제공통계의 생산방법의 적절성, 제공통계의 정확성, 추가적인 자료제공
    가능성 등을 2005년 OECD 요구 산출기준 및 회원국의 산출방법 및 자료 등을 통하여
    검토하고, 이에 따른 관련자료의 정리 및 통계를 생산함.
    ■ 2005년에 신규로 추가된 통계항목에 대해서는 생산방법 및 기준 등을 살펴보고 생산
    가능 통계에 대해서는 추가로 생산 제공함.
    ■ OECD 회원국의 생산수준을 비교하고 선진 회원국의 통계생산에 있어 자료원 및 생산
    방법은 우리나라와 어떤 차이가 있는가를 살펴보기 위하여 OECD에서 제공하는 Data
    그리고 자료원 및 방법을 통하여 회원국의 부문별 생산수준 그리고 생산방법 및 이용
    자료 등을 살펴보고 우리나라와의 차이와 우리나라 통계생산에 적용 가능성을 살펴봄
    ■ OECD에서 요구하는 보건통계 중 미생산통계에 대해서는 향후 생산을 보다 용이하게
    할 수 있도록 통계생산을 위한 방법 및 자료원을 파악하여 제시함.
    ■ 기존 통계개선에 관한 연구결과 등을 고찰하고, 각종 통계의 검토 및 생산방안 마련을
    보다 효율적으로 수행하기 위해 관련부문 전문가의 의견을 적극 수렴하여 연구에 반
    영함.
    ■ 특히 아직 미생산상태로 있는 신부전환자에 대한 통계생산을 위하여 각 분야의 관련
    자료에 대한 검토와 의료기관에 대한 실태조사를 실시하여 신부전환자 통계를 생산함.
    4. 硏究結果
    가. OECD 保健統計 要求 動向
    1) OECD 保健統計 要求 項目의 變化
    ■ OECD 요구 통계 항목 수는 1995년 이후 1998년까지 계속 증가하였으나 1999년에는
    보건부문과 직접적인 관련이 없는 분야를 제외시킴으로써 크게 감소하였음. 즉, 1995
    년 588개 항목에서 점차 증가하여 1998년에는 1,421개 항목에 이르렀으나 1999년에는
    986개 항목으로, 2000년에는 708개 항목으로 크게 감소하였으나, 2001년에는 715개 항
    목으로 7개 항목이 증가하였음. 2002년에는 701개 항목으로 14개 항목이 다시 감소하
    였으며, 2003년에는 이 보다 적은 532개 항목으로 그리고 2004년에는 436개 항목,
    2005년에는 410개 항목으로 감소하여 왔음.
    2) OECD 保健統計 部門別 要求動向
    ■ 2005년도 요구분야는 전년도와 같이 7개의 분야로 구분하여 통계를 요구하였으며, 요
    구항목은 410개 항목으로 전년도에 비하여 26개 항목의 감소를 보였음.
    ― 분야별 변동상황을 살펴보면 가장 큰 변화를 보인 분야는 건강상태로 암 분야에서
    24개 항목 등이 감소하는 등 25개 항목이 감소하였으며, 보건비용에서는 7개 항목
    이 감소하였고, 보건의료자원에서는 6개 항목이 증가하였음.
    ■ 요구분야의 분포를 보면 보건비용분야 및 보건의료이용분야가 각각 139개 항목(33.9%)
    으로 가장 많았고, 의약품시장이 42개 항목으로 10.2%를 점하였으며, 그밖에 건강상태,
    보건의료자원, 보건의 비의료결정요인, 사회보장 등은 10% 미만의 항목을 요구하였음.
    나. OECD 會員國의 保健統計 提出現況: 2004
    ■ 2004년판 OECD Health Data CD ROM에서 각국의 1990~2002년도 기간중 통계 수록
    현황을 기초로 산출한 분야별 수록률은 〈표 3-2〉와 같음. 이 수록률은 각 회원국이
    OECD에 제출한 자료 중 CD-ROM에 수록된 항목에 대한 비율을 제시한 것임.
    ■ 2004년판 OECD Health Data CD ROM에 수록된 통계항목은 OECD에서 요구하여 제출
    한 436개 항목 중 395개 항목임.
    ― 제외된 항목은 41개 항목으로 이들은 회원국의 제출률이 극히 낮은 항목 등이다.
    따라서 여기서는 2004년 OECD Health Data CD ROM에 수록된 395개 항목에 대하
    여 회원국들의 제출비율을 분석한 것임.
    ■ 2004년 회원국의 평균 수록률은 76.6%로 전년도에 비하여 약간 높아진 것으로 나타났음.
    ― 2004년의 회원국별 수록률을 보면 호주가 96.4%로 가장 높고, 다음은 덴마크로
    92.6%로, 3위는 프랑스로 90.0%의 수록률을 보였으며, 우리나라는 62.7%로 평균보
    다 낮은 수록률을 보였음.
    ― 건강상태 관련 통계가 가장 많이 수록된 국가는 프랑스로 100.0%의 수록률을 보였
    으며, 그 외에 90% 이상의 수록률을 보인 국가는 한국, 호주, 오스트리아, 벨기에,
    체코, 덴마크, 핀란드, 독일, 아이슬란드, 이탈리아, 일본, 네덜란드, 뉴질랜드, 노르
    웨이, 슬로바키아, 스웨덴, 스위스, 영국 등 18개 국임.
    ― 보건의료자원분야에서 가장 많은 통계가 수록된 국가는 캐나다와 슬로바키아, 스위
    스로 95.2%의 수록률을 보였으며, 그 외에 90%이상의 수록률을 보인 국가는 프랑
    스, 헝가리, 이탈리아, 룩셈부르크, 네덜란드, 터키, 미국 등 8개국이며, 우리나라는
    47.6%로 회원국의 평균 81.9%에 크게 못 미치고 있음.
    ― 보건의료이용분야 관련 통계가 가장 많이 수록된 국가는 호주와 캐나다, 스위스로
    100.0%의 수록률을 보였으며, 그 외에 90% 이상의 수록률을 보인 국가는 벨기에,
    덴마크, 핀란드, 프랑스, 아이슬란드, 아일랜드, 이탈리아, 룩셈부르크, 멕시코, 뉴질
    랜드, 포르투갈, 영국 등 12개국이며, 우리나라는 64.0%로 전체 평균 81.9%에 못 미
    치고 있음.
    ― 보건비용 관련 통계가 가장 많이 수록된 국가는 독일로 94.3%의 수록률을 보였으
    며, 그 외에 일본이 90% 이상의 수록률을 보였으며, 우리나라는 41.5%로 전체 평균
    60.4% 보다는 낮은 것으로 나타났음.
    ― 사회보장분야 관련 통계가 가장 많이 수록된 국가는 한국, 호주, 오스트리아, 캐나
    다, 덴마크, 핀란드, 프랑스, 독일, 그리스, 헝가리, 아이슬란드, 아일랜드, 일본, 룩셈
    부르크, 뉴질랜드, 노르웨이, 포르투갈, 스위스, 터키, 영국 등 20개국이 100.0%의 수
    록률을 보였으며, 전체 평균 86.7%의 수록률을 보였음.
    ― 의약품시장분야 관련 통계가 가장 많이 수록된 국가는 덴마크와 헝가리, 아이슬란
    드, 스웨덴으로 100.0%의 수록률을 보였으며, 그 외에 90% 이상의 수록률을 보인
    국가는 호주, 체코, 핀란드, 노르웨이, 포르투갈, 슬로바키아 등 6개 국이며, 우리나
    라는 31.7%로 전체 평균 50.6%에 못 미치고 있음.
    ― 보건의 비의료결정요인분야 관련 통계가 가장 많이 수록된 국가는 한국, 호주, 덴마
    크, 프랑스, 독일, 헝가리, 아일랜드, 일본, 네덜란드, 뉴질랜드, 노르웨이, 폴란드, 포
    르투갈, 스웨덴, 영국, 미국 등 14개국이 100.0%의 수록률을 보였으며, 전체 평균은
    89.3%의 수록률을 보였음.
    다. 2005年 OECD 保健統計 提出現況
    ■ 2005년 현재 OECD에서 요구하는 통계항목은 410개 항목이며, 우리나라에서 제출한
    통계 항목수는 258개로 전년도에 비하여 약간 높은 62.9%의 제출률을 보였음.
    ― 건강상태 관련 통계는 40개 항목 중 34개 항목에 대한 통계를 제출하여 85.0%의
    제출률을 보였음. 이들을 세부분야로 살펴보면 제출이 부진한 분야는 선천성이상
    관련 통계분야임.
    ― 보건의료자원분야는 26개 항목에 11개 항목을 제출하여 42.3%의 제출률을 보였음.
    이를 보다 세분화하여 살펴보면 보건부문종사자 관련 통계가 11개 항목 중 3개 항
    목만을 제출하여 부진함을 보였고, 임직원대 병상비율도 제출하지 못하였음.
    ― 보건의료이용 분야는 139개 항목에 대한 통계를 요구하였으며, 이 가운데 97개의
    통계를 제출하여 69.8%의 제출률을 보였음.
    ― 보건비용 관련통계도 139개 항목을 요구하였으며, 요구 통계 항목 중 79개 항목
    을 제출하여 56.8%의 제출률을 보였음. 보다 세분하여 제출이 부진한 분야를 살
    펴보면 입원치료비용, 주간치료비용, 외래치료비용, 재가진료비, 보조서비스, 물가
    지수 등과 관련된 통계의 제출이 부진하였음.
    ― 사회보장관련 통계는 모두 8개 항목으로 구성되어 있으며, 우리나라는 이들 모두
    를 제출하여 100.0%의 제출률을 보였음.
    ― 의약품시장 관련 통계는 모두 42개의 항목으로 이루어져 있으며, 이 가운데 14개
    만을 제출하여 33.3%의 제출률을 보였음. 의약품소비와 의약품 판매로 대분되는
    통계 가운데 의약품소비와 관련된 통계의 제출이 극히 부진하였음.
    ― 보건의 비의료 결정요인과 관련된 분야의 통계는 모두 15개 항목으로 구성되어
    있음. 우리나라는 이들 통계를 모두 제출하여 사회보장관련 통계와 함께 100.0%
    의 제출률을 보인 분야임.
    ■ OECD에서 요구한 48개 통계표별로 구분하여 우리나라의 통계제출현황을 살펴보면 1
    개 연도도 제출하지 못한 통계표가 48개 표 중 9개에 달하였음. 특히 OECD에서 점차
    그 중요성을 강조하고 있는 보건비용분야에서 19개표 중 4개표에 대한 통계를 전혀
    제출하지 못하였음.
    라. 腎不全患者 實態
    ■ 신장학회에서 확보한 투석을 시행중인 439개 의료기관을 대상으로 신부전환자실태조
    사를 실시한 결과 82.7%의 응답률을 보였으며, 응답기관이 제시한 신부전환자수는 혈
    액투석 21천명, 복막투석 6.8천명이였음.
    ■ 건강보험을 통한 2003년 11월부터 2004년 12월까지의 월별 신부전환자의 진료비 청구
    건수를 살펴보면 혈액투석은 최저 약 27천건에서 최고 30천건에 이르고 있으며, 복막
    투석은 최저 7.4천건에서 최고 8.5천건에 이르고 있음.
    ― 또한 기능중인 신장이식은 최저 7042건에서 최고 7896건에 이르고 있음. 이들 청
    구건수는 투석의 특성상 한달에도 몇차례 이루어질 수 있기 때문에 중복이 발생하
    는데 2004년 12월의 경우 중복을 제외하면 혈액투석은 25,417명, 복막투석은 6,796
    명 그리고 기능중인 신장이식은 7,086명인 것으로 나타났음.
    ■ 2004년 9월 현재 신부전 등록 환자수는 37,350명에 이르고 있는 것으로 나타났음. 1급
    이 1,196명, 2급이 29,509명, 4급이 124명, 5급이 6,521명이었음.
    ■ 의료기관제출자료와 건강보험자료를 통합한 결과를 최종적으로 의무기록자료와 확인
    한 결과 성명의 오류나 비해당, 누락 등이 있었으나 영향을 미칠 정도의 크기는 아니
    였음.
    ■ 건강보험자료에서 2004. 12월 기간중 진료를 받은 환자와 의료기관으로부터 2004년 12
    월 환자로 통보된 환자를 통합하여 분석한 결과 혈액투석 약 27.7천명, 복막투석 약
    7.7천명, 기능중인 신장이식이 약 7.1천명이였음.
    마. OECD 要求 未生産統計의 生産方案
    ■ 결근관련 통계는 ‘결근’관련 통계는 근로자를 중심으로 조사가 이루어지거나 직장단위
    보고에서 파악하는 방법이 고려될 수 있으므로 노동부에서 매월 실시하고 있는 ‘노동
    통계조사’1)에 관련 항목이 포함되어 조사될 수 있도록 노동부에 협조 요청
    ■ 보건부문종사자수는 활동의사 중 여성, 일반 및 전문의사 수가 구분될 수 있도록 기존
    의 ‘의료기관실태보고’ 서식을 개정하고, 기타 보건부문 종사자 등에 대하여는 기존의
    ‘환자조사’에 조사항목을 추가하여 조사할 수 있는 방안 강구
    ■ 선천성대사이상은 2000년부터 추진하고 있는 ‘미숙아 및 선천성이상아 등록사업’의 조
    기 정착을 통하여 의료기관 신고율을 제고하고, 출생증명서에 선천성이상과 관련된 사
    항이 상세히 기재될 수 있도록 관련 서식을 개정(의료법시행규칙 제14조)하며, 상기 개
    선사업을 통하여 선천성 이상아에 대한 DB을 구축하고, 구축된 DB와 국민건강보험공
    단자료를 활용하여 의료기관을 통한 실태조사를 실시하고, 축적된 자료를 활용하여 선
    천성 이상아 예방대책 등 관련 정책의 수립에 활용할 수 있는 “선천성이상아 모니터
    링체계 및 통계생산시스템”을 구축
    ■ 수술통계는 국민건강보험공단자료를 활용한 생산방안을 추진하되, 비급여 자료에 대하
    여는 의료기관에 대한 표본조사 등을 통하여 보완하며, 의료기관 조사는 ‘2005년 실시
    예정인 ’환자조사‘를 활용하여 추정하는 방안을 우선 모색함.
    ■ 의약품시장은 외국의 선진모델(호주 등)을 분석하여 우리 실정에 맞는 통계 생산 모형
    을 개발하고, 의약품과 관련된 통계의 생산은 많은 시간과 비용이 소요되므로 상기 연
    구결과를 토대로 장기적인 별도 생산계획을 마련하여 점차적으로 생산을 확대함.
    5. 要約 및 政策提言
    ■ 2005년 현재 OECD에서 요구하는 통계항목은 410개 항목이며, 우리나라에서 제출한
    통계 항목수는 258개로 전년도에 비하여 약간 높은 62.9%의 제출률을 보였음.
    ? 건강상태 관련 통계는 40개 항목 중 34개 항목에 대한 통계를 제출하여 85.0%의 제
    출률을 보였음. 이들을 세부분야로 살펴보면 제출이 부진한 분야는 선천성이상 관
    련 통계분야임.
    ? 보건의료자원분야는 26개 항목에 11개 항목을 제출하여 42.3%의 제출률을 보였음.
    이를 보다 세분화하여 살펴보면 보건부문종사자 관련 통계가 11개 항목 중 3개 항
    목만을 제출하여 부진함을 보였고, 전문인 소득, 임직원대 병상비율은 한 항목도 제
    출하지 못하였음.
    ? 보건의료이용 분야는 139개 항목에 대한 통계를 요구하였으며, 이 가운데 97개의
    통계를 제출하여 69.8%의 제출률을 보였음.
    ? 보건비용 관련통계는 139개 항목으로 이중 79개 항목을 제출하여 56.8%의 제출률을
    보였음. 보다 세분하여 제출이 부진한 분야를 살펴보면 입원치료비용, 주간치료비
    용, 외래치료비용, 재가진료비, 보조서비스, 물가지수 등과 관련된 통계의 제출이 부
    진하였음.
    ? 사회보장관련 통계는 모두 8개 항목으로 구성되어 있으며, 우리나라는 이들 모두를
    제출하여 100.0%의 제출률을 보였음.
    ? 의약품시장 관련 통계는 모두 42개의 항목으로 이루어져 있으며, 이 가운데 14개
    만을 제출하여 33.3%의 제출률을 보였음. 의약품소비와 의약품 판매로 대분되는 통
    계 가운데 의약품소비와 관련된 통계의 제출이 극히 부진하였음.
    ? 보건의 비의료 결정요인과 관련된 분야의 통계는 모두 15개 항목으로 구성되어 있
    음. 우리나라는 이들 통계를 모두 제출하여 사회보장관련 통계와 함께 100.0%의 제
    출률을 보인 분야임.
    ■ 통계생산을 위한 인프라 구축 강화
    통계의 효율적인 생산을 위해 이를 담당할 조직, 인력, 예산, 법 제도의 뒷받침이 되어
    야 하나 이들 기반이 매우 취약함. 따라서 보건통계 전반을 기획?조정하는 중앙기관의
    인력 및 조직 보강 그리고 전담기관의 설립, 전문인력의 양성, 법 제도의 개선, 예산의
    확보 등이 요구됨.
    ? 우리나라의 경우 보건통계생산 및 관리를 담당하고 있는 인원이 매우 적어 체계적
    인 생산이나 관리보다는 직면한 문제 해결에 급급한 실정임. 이를 해결하기 위해
    통계생산 조직 및 인력의 보강이 요구됨.
    ? 미국, 호주, 일본 등에서는 보건통계의 효율적인 생산을 위한 조직 및 인력을 가
    지고 있음. 이는 통계생산의 확대와 질 높은 통계생산의 가능성이 다른 국가보
    다 높다는 것을 의미함.
    ? 우리나라도 보건통계생산을 기획하고 관장할 수 있는 센터의 설립이 요구됨. 이를
    통해 모든 보건통계의 생산을 위한 장?단기 계획을 수립하고 추진할 수 있는 역할
    을 수행하도록 하여야 할 것임.
    ? 보건통계센터는 우리나라 보건통계생산 활동을 전부 수행하는 조직이 아니라 각
    통계생산 주체가 일관된 목표를 갖고 통계생산활동을 할 수 있도록 보건통계 전
    반을 기획?조정하며 통계 결과에 대한 평가, 행정 및 기술적 지원, 생산된 통계
    자료의 집중 관리 등의 기능을 수행하며, 대외적으로 우리나라 보건통계생산기
    관을 대표하는 위상을 가져야 함.
    ? 효율적인 통계생산은 제도권안에서 안정되게 추진되는 것임. 따라서 효율적인 통계
    생산이 가능하도록 법 및 제도의 정비가 요구됨.
    ? 의료기관을 통해 생산 가능한 통계는 제출을 의무화하는 방안의 추진이 필요하
    며, 이에 따른 직?간접적인 지원방안도 강구되어야 할 것임.
    ? 통계를 효율적으로 생산하기 위하여서는 생산기반의 구축과 함께 예산의 지원이 필
    수적임. 각종 사업 추진시 일정비율에 해당하는 예산은 통계생산에 활용토록 하여
    다양한 통계가 주기적으로 생산될 수 있도록 하여야 할 것임.
    ? 소유정보의 공유
    ? 각 기관별 생산통계 뿐만 아니라 보건복지통계생산과 관련된 어떤 자료를 보유하
    고 있는지를 서로 공유할 수 있도록 제도화함.
    ? 소유 자료의 공동활용방안 모색
    ? 여러 기관이 개별적으로 통계를 생산하고 있으므로 통계의 품질을 관리될 수 있
    는 방안에 관심을 기울여야 하며 이를 위하여 통계적 메타데이터를 통한 품질관
    리 방안이 필요함.
    ? 통계적 메타데이터는 통계자료를 설명하는 문서로 통계자료에 대한 이해를 돕고
    생성과정이나 의문점들을 해소할 수 있음. 특히 동일한 방법으로 반복되는 조사
    사업에 있어서는 조사가 효율적으로 이루어지도록 하는 지침서가 됨.
    ? 관련 행정가와 통계생산을 위한 공조체제 구축
    ? 생산통계의 정책활용도를 높이기 위하여는 가장 필요한 통계가 우선적으로 생산
    되어야 하므로 행정가와 통계 생산 담당자와의 상호협의를 통해 생산이 가능하도
    록 협의체제를 구축토로 함.
    ? 점차적으로 행정업무수행 과정에서 얻어지는 각종 자료가 통계화하여 보다 현장
    감 있는 통계가 될 수 있도록 유기적인 협조체제를 구축함.
    ? 일반 국민의 보건복지수요을 파악하고, 요구통계를 우선적으로 생산
    ■ 신부전환자 관련 통계의 주기적 생산을 위한 생산체계의 구축
    ? 신부전환자 관련 통계의 효율적인 생산을 위하여 관련 자료의 연계 활용이 요구됨.
    따라서 건강보험자료를 기반으로 신장학회 수집자료를 활용하고, 일부 의료기관에
    대한 확인조사를 병행하여 통계를 생산하여 장기적으로는 장애등록자료의 활용도
    적극 검토되어야 할 것임.
주제어
발행년도 2005

연구결과 평가 및 활용보고서

평가결과서, 활용결과보고서의 정보를 제공합니다.
평가결과서
활용결과 보고서

공공누리 정보